If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Tirzepatide
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Tirzepatide: Use in Patients With Gastroparesis
Tirzepatide has not been studied in people with delayed gastric emptying.
cFAQ
cFAQ
US_cFAQ_TZP320_USE_IN_PATIENTS_WITH_GASTROPARESIS
en-US
Detailed Information
There is no information on the use of tirzepatide in people with gastroparesis because patients were excluded from tirzepatide clinical trials if they had a known clinically significant gastric emptying abnormality (for example, severe diabetic gastroparesis or gastric outlet obstruction).
Date of Last Review: February 05, 2021
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST